about
The effect of clopidogrel, aspirin and both antiplatelet drugs on platelet function in patients with peripheral arterial diseaseThe effect of a loading dose (300 mg) of clopidogrel on platelet function in patients with peripheral arterial diseaseApproach to the assessment of platelet function: comparison between optical-based platelet-rich plasma and impedance-based whole blood platelet aggregation methodsAllyl sulfides modify cell growth.Involvement of P2Y receptors in the differentiation of haematopoietic cells.Surface modification of PVDF using non-mammalian sources of collagen for enhancement of endothelial cell functionality.Modeling thrombus formation and growth.Calcium integrin-binding protein activates platelet integrin alpha IIbbeta 3.Platelet-rich concentrate in serum free medium enhances osteogenic differentiation of bone marrow-derived human mesenchymal stromal cells.Molecular cloning and expression analysis of P-selectin from Zebrafish (Danio rerio).Three-stage ex vivo expansion of high-ploidy megakaryocytic cells: toward large-scale platelet production.Hemolysate-mediated platelet aggregation: an additional risk mechanism contributing to thrombosis of continuous flow ventricular assist devices.Isolation of Bioactive Compounds That Relate to the Anti-Platelet Activity of Cymbopogon ambiguus.On-chip evaluation of platelet adhesion and aggregation upon exposure to mesoporous silica nanoparticles.Leukocyte count and leukocyte ecto-nucleotidase are major determinants of the effects of adenosine triphosphate and adenosine diphosphate on platelet aggregation in human blood.The influence of bromelain on platelet count and platelet activity in vitro.PDK1 governs thromboxane generation and thrombosis in platelets by regulating activation of Raf1 in the MAPK pathway.Platelet activation parameters and platelet-leucocyte-conjugate formation in glioblastoma multiforme patients.
P2860
Q28168691-C2FEF2FE-A6CA-4F9A-A23B-CDDBD77D8692Q28196480-EC6E6B05-36FE-4F66-89AE-E4780E6A6250Q28213984-94A3AB6D-BE6B-4A7A-852D-CE3D8C3018E9Q34153271-4CD3F892-1B87-44EB-9007-DEDFEA1CAD7FQ35093125-8C45D43B-7815-46A6-BF40-981396076CF4Q36456292-468589AD-5DD3-4449-941E-10E8B98519F6Q39329081-B2190A24-8BF4-4EC8-AE92-A57433AE0744Q40769287-7FB12767-6F16-4418-8DE2-A3C286454056Q41062876-47659A8C-1669-4C74-9AA5-916760A3FF6FQ41106899-9374EDDF-A342-4733-9A45-5D835B25384FQ41433371-897E859C-97AE-49C0-80CB-0B1434AD1816Q42772762-2735029B-5D81-4BCC-A05B-3E3D63505BD1Q42802611-10B57D18-B69E-4979-881D-C1BA72CFC87FQ46596056-1018F865-6806-4735-976C-36B85773BA36Q46596616-A4E0AF3C-E052-4358-9253-B2430C4EF20FQ46820388-CC016BE1-436C-4722-A23F-81387ABD458DQ54119484-DA2AA39B-E5F2-4CDD-BCFC-C766FA00FDB6Q55098679-7A3F1226-9E7D-476C-89DD-3992485269B2
P2860
description
1997 nî lūn-bûn
@nan
1997年の論文
@ja
1997年論文
@yue
1997年論文
@zh-hant
1997年論文
@zh-hk
1997年論文
@zh-mo
1997年論文
@zh-tw
1997年论文
@wuu
1997年论文
@zh
1997年论文
@zh-cn
name
ADP-induced platelet activation.
@en
type
label
ADP-induced platelet activation.
@en
prefLabel
ADP-induced platelet activation.
@en
P2860
P1476
ADP-induced platelet activation.
@en
P2093
P2860
P304
P356
10.3109/10409239709082000
P577
1997-01-01T00:00:00Z